BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8794517)

  • 1. Exaggerated responsivity of brain dopaminergic system activity in schizophrenia: a preliminary finding of increased variance of plasma homovanillic acid level in a chronic patient.
    Fukuda M; Niwa S; Hiramatsu K; Hata A; Nakagome K; Iwanami A; Honda H
    Schizophr Res; 1996 May; 20(1-2):241-4. PubMed ID: 8794517
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma vanillylmandelic acid level as an index of psychological stress response in normal subjects.
    Fukuda M; Hata A; Niwa S; Hiramatsu K; Honda H; Nakagome K; Iwanami A
    Psychiatry Res; 1996 Jun; 63(1):7-16. PubMed ID: 8832769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of free homovanillic acid, (3-methoxy-4-hydroxyphenyl)ethylene glycol, and vanilmandelic acid in human plasma by high-performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection.
    Gerhardt GA; Drebing CJ; Freedman R
    Anal Chem; 1986 Nov; 58(13):2879-83. PubMed ID: 3813021
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
    Hatzimanolis J; Lykouras L; Markianos M; Oulis P
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of unconjugated homovanillic acid, vanilmandelic acid, and 3-methoxy-4-hydroxyphenylethylene glycol, in serum by mass fragmentography and deuterated internal standards.
    Muskiet FA; Nagel GT; Wolthers BG
    Anal Biochem; 1980 Nov; 109(1):130-6. PubMed ID: 7469009
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D; Breier A; Hsiao JK; Doran AR; Wolkowitz OM; Pato CN; Konicki PE; Potter WZ
    Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology.
    Markianos M; Botsis A; Arvanitis Y
    Biol Psychiatry; 1992 Aug; 32(3):288-92. PubMed ID: 1384728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous analysis of homovanillic acid, 5-hydroxyindoleacetic acid, 3-methoxy-4-hydroxyphenylethylene glycol and vanilmandelic acid in plasma from alcoholics by high-performance liquid chromatography with electrochemical detection. Critical comparison of solid-phase and liquid-liquid extraction methods.
    Hartleb J; Eue S; Kemper A
    J Chromatogr; 1993 Dec; 622(2):161-71. PubMed ID: 7512090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic response to stress: a protective factor against abnormal dopaminergic reactivity in schizophrenia?
    Brunelin J; D'amato T; van Os J; Dalery J; Suaud-Chagny MF; Saoud M
    Eur Psychiatry; 2007 Sep; 22(6):362-4. PubMed ID: 17419010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Plasma and red blood cell concentrations of risperidone and its 9-hydroxymetabolite and their relationship to whole blood serotonin and tryptophan, plasma homovanillic acid, 5-hydroxyindoleacetic acid, dihydroxyphenylethyleneglycol and clinical evaluations.
    Aymard N; Viala A; Clement MN; Jacquot M; Vacheron MN; Gauillard J; Caroli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):975-88. PubMed ID: 12369274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensory physiology and catecholamines in schizophrenia and mania.
    Adler LE; Gerhardt GA; Franks R; Baker N; Nagamoto H; Drebing C; Freedman R
    Psychiatry Res; 1990 Mar; 31(3):297-309. PubMed ID: 2333360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic balance and subtypes of schizophrenia.
    Dávila R; Zumárraga M; Andia I; Manero E; Retuerto F; Barcena B; Guimón J
    Br J Psychiatry Suppl; 1989 May; (4):57-60. PubMed ID: 2690881
    [No Abstract]   [Full Text] [Related]  

  • 13. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
    Watanabe K; Miura I; Kanno-Nozaki K; Horikoshi S; Mashiko H; Niwa S; Yabe H
    Psychiatry Res; 2015 Dec; 230(2):419-23. PubMed ID: 26416588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term storage on the concentrations of the unconjugated acidic metabolites of the trace amines, indoleamines and catecholamines.
    Davis BA
    J Chromatogr; 1988 Dec; 433():23-30. PubMed ID: 2466860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the central dopaminergic index of plasma HVA in schizophrenia.
    Amin F; Davidson M; Kahn RS; Schmeidler J; Stern R; Knott PJ; Apter S
    Schizophr Bull; 1995; 21(1):53-66. PubMed ID: 7770741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.
    Waldo MC; Cawthra E; Adler LE; Dubester S; Staunton M; Nagamoto H; Baker N; Madison A; Simon J; Scherzinger A
    Schizophr Res; 1994 May; 12(2):93-106. PubMed ID: 8043530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia.
    Kuniyoshi M; Nakamura J; Miura C; Inanaga K
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):339-46. PubMed ID: 7516085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects.
    Waldo M; Gerhardt G; Baker N; Drebing C; Adler L; Freedman R
    Psychiatry Res; 1992 Oct; 44(1):21-32. PubMed ID: 1461944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M; Davis KL
    Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic contribution to cognitive sequence learning.
    Nagy O; Kelemen O; Benedek G; Myers CE; Shohamy D; Gluck MA; Kéri S
    J Neural Transm (Vienna); 2007; 114(5):607-12. PubMed ID: 17347774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.